Vessel Resection and Reconstruction of Biliary Tract Cancers

To investigate the vessel resection and reconstruction in biliary tract cancer.

Completed

Looking for future studies?

Key information

Conditions

Biliary Tract Cancer Biliary Tract Diseases Biliary Tract Neoplasms Digestive System Diseases Digestive System Neoplasms Neoplasms Neoplasms by Site

Sex eligibility

All sexes

Study type

Observational

Primary location

Osaka University, Graduate School of Medicine

Osaka, 565-0871, Japan

About this study

The vessel resection and reconstruction of hepatic artery and portal vein in biliary tract cancer surgery is still controversial. In this study, we retrospectively evaluate the diagnostic image, pathology, peri-operative events, recurrence, and prognosis in these patients, as a multi-center surveillance.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Cases of vessel resection and reconstruction in biliary tract cancer.

Exclusion criteria

Treatment and study plan

Primary outcomes

Comparison of vascular invasion in diagnostic image and in pathology.

Time frame: 20 years
R0 resection rate

Time frame: 20 years

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

Kansai Hepatobiliary Oncology Group

Network

Registry information

Official study title

Resection and Reconstruction of Major Vessels in Biliary Tract Cancers

Important dates

Study start: 2013
Primary completion: 2014
Study completion: 2014
First posted: May 23, 2013
Registry last updated: Jul 1, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed